A PPAR-independent pathway to PUFA-induced COX-2 expression
Introduction
Various hormones interact with G-protein-linked cell surface receptors to activate phospholipases and raise intracellular levels of polyunsaturated fatty acids (PUFAs). A good example is the effect of oxytocin exerted via oxytocin receptors on the epithelium of the uterine endometrium, which leads to activation of phospholipases C and A, releasing arachidonic acid and other PUFAs esterified in phospholipids (Flint et al., 1986). PUFAs produced in this way may then act as second messengers, both through activation of protein kinases and via other metabolic products (Khan et al., 1995, Maloberti et al., 2005).
PUFAs may also be secreted by the cells in which they are generated, to act on neighbouring cells as paracrine messengers (Cooke et al., 1991, Ronco et al., 2002). This has been suggested to occur in the endometrium in relation to both activation of cyclic AMP phosphodiesterase (Cheng et al., 2007) and induction of cyclooxygenase 2 (COX-2; also known as prostaglandin endoperoxide synthase 2; Sheldrick et al., 2007). Evidence for an effect on COX-2 includes the observations that PUFAs raise COX-2 levels in rat uterine stromal cells (Prigent-Tessier et al., 1996) and in bovine endometrial epithelial cells (Parent et al., 2003) through increased COX-2 gene expression and increased levels of COX-2 transcripts (Asselin et al., 1997, Meade et al., 1999). Furthermore, the oxytocin receptor is expressed in the bovine endometrial epithelium at a time when it is not expressed in the stroma (Robinson et al., 1999). Arachidonic acid has therefore been proposed to act as a paracrine signal released during the oestrous cycle by epithelial cells to induce COX-2 in the stroma (Sheldrick et al., 2007). The experiments described here were carried out to investigate the pathways by which PUFAs induce COX-2 gene expression in endometrial stromal cells.
Previous experiments on the mechanism by which arachidonic acid raises COX-2 levels suggest that peroxisome-proliferator-activated receptors (PPARs) mediate PUFA-induced COX-2 expression in the bovine endometrium (MacLaren et al., 2006, Sheldrick et al., 2007). The isoform PPARα appears to be involved in bovine endometrial stromal cells. PPARα is activated directly by a range of PUFAs, including arachidonic acid. However, PPARα function is dependent on phosphorylation by protein kinase C (PKC; Blanquart et al., 2004), which is also activated by PUFAs (Shinomura et al., 1991, Khan et al., 1995). Furthermore, in some cells PKC induces COX-2 through a second pathway, involving NF-κB (Paik et al., 2000, Wu and Wiltbank, 2001, Yan et al., 2002). As a result arachidonic acid may potentially induce COX-2 directly via PPARα and indirectly through PKC/NF-κB.
To distinguish between PPAR-dependent and -independent pathways we have used a reporter construct under the control of a naturally occurring sequence derived from the bovine COX-2 promoter. This construct, which includes most of the important transcription regulators present in the COX-2 promoter but lacks an identifiable peroxisome-proliferator response element (PPRE), allows the study of pathways to COX-2 induction in which PPARs are not involved. Furthermore we have investigated the role of NF-κB in the function of the promoter by sequential removal of the NF-κB sites from this construct.
Section snippets
Materials
All PUFAs; synthetic PPAR agonists; the NSAIDs, indomethacin and NS398; prostaglandin A1 (PGA1); the phorbol ester 4β-PMA and its inactive analogue 4α-phorbol 12,13-didecanoate (4α-PDD); the protein kinase C inhibitor, RO 318425, and the NF-κB inhibitor, MG132 were obtained from either Sigma (Poole, UK) or Calbiochem (Nottingham, UK). Conjugated linoleic acid (Sigma catalogue number O 5507) was a mixture of cis- and trans-9,11- and -10,12-octadecadienoic acids. The PUFAs, indomethacin and
Structure of the COX-2 promoter
The nucleotide sequence of the bovine COX-2 gene promoter is shown in Fig. 1. PPARs form heterodimers with the 9-cis retinoic acid receptor (RXR) to activate target genes by binding to specific response elements (PPREs). PPREs contain two direct repeats of PuGGTCA half-sites separated by one base (usually A) with an additional 4 bases (usually AACT) comprising the 5′ part of binding site, giving the consensus sequence AACTAGGNCAAAGGTCA (the hexameric half-sites being italicised; Ijpenberg et
Discussion
Previous experiments showed that one pathway to induction of COX-2 in uterine stromal cells treated with arachidonic acid involves PPARα (Sheldrick et al., 2007). However, in previous experiments it was not possible to distinguish between an effect of arachidonic acid as a PPAR agonist and that involving activation of PKC and NF-κB. Inhibitors were used to block either PKC or NF-κB, but blocking PKC led to inhibition of the PPAR pathway (as expected based on the requirement for PPARs to be
Acknowledgements
We thank Pat Fisher for isolating the endometrial stromal cells. This work was funded by the Biotechnology and Biological Sciences Research Council and the Wellcome Trust.
References (36)
- et al.
Prostaglandin F2α activates protein kinase C in human ovarian cells
Mol. Cell. Endocrinol.
(1993) - et al.
Inhibition by eicosapentanoic acid of IL-1β-induced PGHS-2 expression in human microvascular endothelial cells: involvement of lipoxygenase-derived metabolites and p38 MAPK pathway
Biochim. Biophys. Acta
(2003) - et al.
Arachidonic acid activates a functional AP-1 and an inactive NF-κB complex in human HepG2 hepatoma cells
Free Rad. Biol. Med.
(2003) - et al.
Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF-κB
FEBS Lett.
(1997) A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein-dye binding
Anal. Biochem.
(1976)- et al.
Release of arachidonic acid and the effects of corticosteroids on steroidogenesis in rat testis Leydig cells
J. Steroid Biochem. Mol. Biol.
(1991) - et al.
Ligand-independent activation of steroid receptors
Dom. Anim. Endocrinol.
(2002) - et al.
Polarity and specific sequence requirement of peroxisome proliferator-acivated receptor (PPAR)/RetinoidX receptor heterodimer binding to DNA
J. Biol. Chem.
(1997) - et al.
Arachidonic acid and free fatty acids as second messengers and the role of protein kinase C
Cell. Signal.
(1995) - et al.
Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through toll-like receptor 4
J. Biol. Chem.
(2001)
The delayed activation of the prostaglandin G/H synthase-2 promoter in bovine granulosa cells is associated with down-regulation of truncated upstream stimulatory factor-2
J. Biol. Chem.
Peroxisome proliferator-activated receptor (PPAR) expression in cultured bovine endometrial cells and response to omega-3 fatty acid, growth hormone and agonist stimulation in relation to series 2 prostaglandin production
Dom. Anim. Endocrinol.
Cellular enrichment with polyunsaturated fatty acids induces an oxidative stress and activates the transcription factors AP1 and NFκB
Biochem. Biophys. Res. Commun.
Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells
J. Biol. Chem.
Two opposing effects of non-steroidal anti-inflammatory drugs on the expression of the inducible cyclooxygenase
J. Biol. Chem.
Inhibition of 5-lipoxygenase and cyclo-oxygenase in leukocytes by feverfew
Biochem. Pharmacol.
Differences in phorbol-ester-induced down-regulation of protein kinase C between cell lines
Biochem. J.
Cellular mechanisms involved during oxytocin-induced prostaglandin F2α production in endometrial epithelial cells in vitro: role of cyclooxygenase-2
Endocrinology
Cited by (16)
Correlation between circulating proteasome activity, total protein and c-reactive protein levels following burn in children
2014, BurnsCitation Excerpt :The possible mechanism of the correlation of 20S proteasome with CRP may be explained by the fact, that increased levels of CRP, or a concomitant increase of inflammatory cytokines, may lead to an increased encoding of ubiquitin and proteasomes, which are part of an intracellular proteolytic system that degrades the bulk of muscle proteins [34]. Recent data suggest that the proteasome inhibitor MG132 prevents fatty acid induction of the pro-inflammatory enzyme cyclooxygenase-2 in endometrial stromal cells [35]. MG132 proteasome inhibitor prevented palmitate- and oleate-mediated increase in CREBh mRNA [36].
Progesterone exposure of the preovulatory follicle in the seasonally anestrous ewe alters the expression of angiogenic growth factors in the early corpus luteum
2012, TheriogenologyCitation Excerpt :Protein expression values (band intensities) were calculated in relation to the controls. Immunoblotting was performed as described previously [38–41] with the following modifications: once cut to size, polyvinyl difluoride (PVDF) membrane (Immobilon-P transfer membranes, Millipore Corporation, Billerica, USA) was soaked in 100% methanol before semidry electrophoretic elution at 25v and 33 mA/gel for 90 min. Membranes were blocked in 10% milk in TBST [50 mm Tris, 150 mm sodium chloride, 0.02% v/v Tween 20, pH 7.4] for 2 h (VEGF, ANG-1, ANG-2 and Tie-2) or overnight (VEGFR-2).
Effects of n-6 polyunsaturated fatty acids on prostaglandin production in ovine fetal chorion cells in vitro in late gestation ewes
2011, PlacentaCitation Excerpt :However, in human endothelial cells AA intensively induced both 2- and 3- series PG production [29], even though 3-series PGs are derived from n-3 PUFAs. Our own previous studies showed that AA stimulated PGHS2 mRNA transcription and expression in BEND cells (derived from bovine endometrium) transfected with PGHS2 [30–32]. AA also increased 1-, 2-, and 3- series PGE and PGF production in uterine endometrial epithelial cells isolated from cyclic ewes and amnion cells in late gestation ewes [33,34].
Involvement of the nuclear factor-κB pathway in the pathogenesis of endometriosis
2010, Fertility and SterilityCitation Excerpt :Studying the effect of NF-κB inhibitors in ECs and EcCs in vitro and in vivo has shown NF-κB inhibition to reduce endometriosis development and maintenance (Table 1). In vitro studies in stimulated ECs and EcCs testing different NF-κB inhibitors—including MG132, parthenolide, SN-50, BAY 11-7085, curcumin, sulindac, thalidomide, N-tosyl-l-phenylalanine chloromethyl ketone (TPCK), GnRH agonists, progesterone, progestational compounds, IKK-2 inhibitor, PPAR-γ ligand (pioglitazone), IL-10, and NF-κB decoy oligonucleotides (ODNs)—have shown a reduction in proinflammatory, growth, and invasion mediators COX-2, IL-6, leukemia inhibitory factor (LIF), MIF, RANTES, IL-8, MCP-1, GM-CSF, ICAM-1, and MMP-9, have reduced cell proliferation, monocyte chemotactic activity, and cell invasion, and have increased apoptosis as a result of decreased NF-κB activation (33, 47, 53–55, 59, 62–64, 67–70, 87, 88, 159, 160). Treating endometriosis induced in nude mice intraperitoneally with BAY 11-7085 and SN-50 was shown to decrease initial endometriotic lesion growth, reducing inflammation and cell proliferation and inducing apoptosis (33).
Therapeutic potential of ω-3 polyunsaturated fatty acids in human autoimmune diseases
2019, Frontiers in Immunology